🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
NVO
$NVO
🔒 US EquitiesNovo-Nordisk A/S SPONS ADR
AVG HISTORICAL GAP
-0.17%
MAX GAP RECORD
-5.71%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $NVO
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$NVO
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Nov 04, 2026 Earnings Release 2026-11-04 (BEFORE OPEN (07:00)) | 🔮 UPCOMING 🔒 |
| Aug 04, 2026 Earnings Release 2026-08-04 (AFTER CLOSE) |
+1.20%
|
| May 05, 2026 Earnings Release 2026-05-05 (AFTER CLOSE) |
+3.21%
|
| Feb 03, 2026 Earnings Release 2026-02-03 (AFTER CLOSE) |
-4.67%
|
| Nov 05, 2025 Earnings Release 2025-11-05 (BEFORE OPEN) |
-2.63%
|
| Aug 06, 2025 Earnings Release 2025-08-06 (BEFORE OPEN) |
-2.65%
|
| May 07, 2025 Earnings Release 2025-05-07 (BEFORE OPEN) |
+4.62%
|
| Feb 04, 2025 Earnings Release 2025-02-04 (AFTER CLOSE) |
+4.61%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
3.0%
Bullish Gaps (6)
Bearish Gaps (7)
Neutral / Flat (2)
📖 Intelligence Summary
Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗